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ABSTRACT 
 
Novel Intraosseous Device Performance and Longevity in a  
 
Goat Model (Capra hircus).  (December 2010) 
 
Erin Elizabeth Jackson, D.V.M., Kansas State University 
 
Chair of Advisory Committee: Dr. Karen Snowden 
 
Two studies were performed to assess the function and longevity of a novel 
intraosseous (IO) catheter device.  For the initial study, nine animals were assigned to 
three study groups.  The first group received a 25 mm intraosseous device within the 
proximal humerus, the second group within the proximal tibia, and standard jugular 
catheters were placed in the final control group.  Serial aerobic and anaerobic blood 
cultures were collected from jugular veins at day zero, then every third day while 
devices remained in use.  Radiographs were obtained immediately after placement and 
again after removal of all IO devices. Goats were observed for overall clinical condition 
and lameness associated with catheter sites, and catheters were evaluated for patency and 
proper positioning. IO devices in the tibia remained in for less time than those in the 
humerus.  Blood cultures in this study showed growth of Bacillus, Staphylococcus, and 
one colony within the genera Brachyacterium or novel Dermabacteraceae.  Catheters 
also showed growth of Bacillus, as well as a single colony of Micromonospora chalcea.  
No animals in either IO group exhibited radiographic evidence of resulting damage or 
structural change within surrounding bone.  In study two, eighteen goats were assigned 
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to two study groups (25 mm intraosseous device within the wing of the ilium, or 45 mm 
catheter in the proximal humerus).  Blood for serial aerobic and anaerobic blood cultures 
and CBC were collected from jugular veins at day zero, then every second day thereafter 
while devices remained in use.  All clinical monitoring and removal criteria were 
identical to study one.  Catheters in the ilium remained in significantly less time than 
those in the humerus.  Several animals in the proximal humerus group demonstrated 
moderate lameness following removal. One goat developed an abscess near the insertion 
site and showed radiographic evidence of periosteal bone growth.   Serial cultures 
showed growth of Bacillus, Streptococcus, Staphylococcus, and Enterococcus.  
Bloodwork indicated mild elevations of white blood cells from baseline in some cases.  
Our study indicated that catheters may remain safely in place for greater than 24 hours, 
but that animals should be closely monitored for negative side-effects for several days 
during the post-removal period. 
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1. INTRODUCTION: INTRAOSSEOUS CATHETER USE IN HUMAN AND  
 
VETERINARY MEDICINE 
 
 Intravenous administration of fluids and medication is a crucial component of 
emergency medical case management.  However, venous access is often extremely 
difficult to obtain in severely compromised patients.  A cutdown procedure can be time-
consuming and difficult for those inexperienced with the technique, and ultimately still 
may not succeed in gaining intravenous (IV) access during severe hypovolemia. The 
spectrum of drugs that may be given via the endotracheal route is limited, and their rate 
of distribution may be variable33,38,39.  Also, the endotracheal route is obviously not an 
option for fluid replacement.  In such instances where IV access is not readily accessible, 
intraosseous (IO) catheterization may serve as a reliable, life-saving alternative.  This 
technique is frequently used in veterinary medicine, particularly in pediatric and exotic 
animal species.  In veterinary medicine, the most common locations for intraosseous 
catheterization are the proximal humerus, proximal tibia, wing of the ischium, iliac crest, 
and the proximal femur19,56.  While a number of studies have been performed on efficacy 
and potential applications of IO catheters in several veterinary species, including dogs, 
swine, and goats5,12,18,30,45,46, there are limited data regarding use over an extended time 
period.  It is generally recommended that IO catheters be removed as soon as venous 
access is attainable.  However, it is conceivable that complications or other factors may 
arise, necessitating the use of an IO cannula for longer than anticipated.   
 
_____________ 
This thesis follows the style of Comparative Medicine. 
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These devices have also gained a renewed interest within the human emergency 
medical community.  While IO access has been most commonly utilized in human 
pediatrics, more recent attention has been given to its potential for use in adult 
emergency care and for military special operations.   
Several devices have been introduced for IO catheterization, including the EZ-
IO® (Vidacare, San Antonio, TX).  This high-powered drill allows for control and 
minimal tissue damage, and may be placed at multiple anatomic sites with or without the 
use of local anesthetics.   The EZ-IO® comes in several sizes, and is currently approved 
by the FDA for 24 hour use in the human tibia and humerus25.  These needles are 
quickly situated, and several studies have shown that use of these devices and their 
proper placement are easily learned regardless of experience level2,6,11,31,35.   The EZ-IO® 
has recently become available for use in veterinary medicine. We feel that in addition to 
the more typical small animal veterinary uses, these automatic drills may prove quite 
useful in large animal species of all ages, where manual placement of an intraosseous 
catheter may be difficult and time consuming. Our aim, therefore, was to evaluate the 
extended safety and efficacy of these devices for potential implications in large and 
small animal practice. 
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2. MATERIALS AND METHODS 
 
2.1. Study One   
Nine young adult domestic goats (Capra hircus) weighing between 27 kilograms 
and 40 kilograms were determined to be normal by physical examination (Texas A&M 
Veterinary Medical Park, College Station, TX, USA).  All goats were housed in groups 
of three within approved laboratory animal facilities for the duration of the study, and 
used under a protocol approved by the Texas A&M Institutional Animal Care and Use 
Committee. Animals were assigned to one of three groups (IO device in the proximal 
tibia, IO device in the proximal humerus, or jugular catheter).  Catheters (25 mm) 
utilized in this study were labeled for use in human patients 40 kilograms or greater in 
weight. Thus the six goats who most closely met the weight criteria were then randomly 
assigned to receive an indwelling device, either within the proximal tibia (n=3) or 
proximal humerus (n=3). The remaining three animals received a jugular catheter. 
 An intramuscular injection of 0.22 mg/kg xylazine (Butler Animal Supply, 
Dublin, OH) was administered, followed by intramuscular 11 mg/kg ketamine (Fort 
Dodge, Fort Dodge, IA) for induction of general anesthesia.  Areas surrounding 
cannulation sites were clipped and prepared aseptically, and sterile technique was used 
for all device placements.  Intraosseous devices were inserted according to manufacturer 
instructions, following aseptic preparation of the skin and a subcutaneous injection of 
0.2ml of lidocaine (Sparhawk Laboratories, Lenexa, KS) immediately over the insertion 
point.  The catheters were then placed through the skin and bone using the EZ-IO® high-
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powered drill.  Tibial devices were applied medially, placing the needle perpendicular to 
the bone, approximately one inch below the tibial tuberosity (Figures 1 and 2).  Devices 
in the humerus were placed longitudinally within the head of the humerus. (Figures 3 
and 4) In both, intramedullary placement was confirmed by firm seating and aspiration 
of blood and marrow contents.  An EZ Connect® cap was then attached after removal of 
the stylet, and baseline radiographs were obtained for all IO sites prior to anesthetic 
recovery.  Tibial IO devices were covered with a light wrap.  Due to positioning, 
wrapping the devices in the humerus was not feasible.  Jugular catheters were set in the 
classic fashion after skin preparation, using an 18g, 2” vinyl intravenous catheter 
(Emergency Medical Products, Waukesha, WI).  Once blood flow was confirmed by 
aspiration, the catheter was secured to the skin using a small amount of skin glue and a 
3-0 PDS suture (Butler Animal Health, Dublin, OH).   
     Approximately 3 ml of blood was collected from the jugular veins of all animals 
for baseline aerobic and anerobic cultures.  Samples were submitted to the Texas 
Veterinary Medical Diagnostic Laboratory (TVMDL, College Station, TX) in 20 ml 
pediatric soy tryptinase blood culture media (Becton, Dickinson and Co, Sparks, MD). 
After flushing the catheter with 3 ml of 100U/10ml heparin (American Pharmaceutical 
Partners, Inc, Shaumburg, IL) saline (Butler Animal Health, Dublin, OH) flush as per 
manufacturer recommendations, the site was covered with a light wrap and the animal 
allowed to recover. 
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Figure 1.  Radiographic view (caudal aspect) of proximal tibial intraosseous catheter 
placement. 
 
 
Figure 2.  Medial view of proximal tibial intraosseous catheter in left leg. 
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Figure 3.  Radiographic view (lateromedial) of proximal humerus intraosseous catheter 
placement. 
 
 
 
Figure 4.  Lateral view of proximal humerus intraosseous catheter in the left leg. 
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Throughout the duration of the study, animals were observed at least twice daily 
by study personnel for overall condition, appetite, device-associated lameness, or any 
redness or swelling at the catheter sites.  Each day, rectal temperatures were obtained 
and all catheters were evaluated for patency, as well as for firm seating within the bone.  
The ability to aspirate enough blood for culture through the cannulations varied among 
animals, therefore, all samples were collected from the jugular veins for consistency.  
Blood collection was performed every third day while catheters remained in place.  
Upon manual removal of IO devices by study personnel, catheters were submitted to 
TVMDL for aerobic and anaerobic culture.  All goats with IO catheters still in place at 
the time of failure also underwent a second general anesthesia (0.22 mg/kg xylazine IM 
and 11mg/kg IM ketamine) for removal and follow-up radiographs.   
Any catheters not flushing easily due to clogging or poor positioning were 
removed immediately. Other criteria for removal included: temperature exceeding 
103.1ºF for greater than 24 hours, pain or lameness associated with the device, excessive 
redness, swelling, or discharge around insertion sites, and inappetance, lethargy, or other 
behavioral changes.  Animals showing any of the aforementioned clinical signs were 
administered appropriate antibiotics (long-acting ceftiofur or tulathromycin) and/or 
analgesic medication (phenylbutazone) as needed, and all animals were placed on 
observation for 24-48 hours.  After confirmation of good health status, goats were then 
returned to regular pasture housing. 
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2.2. Study Two  
Eighteen young adult domestic goats (Capra hircus) weighing approximately 40 
kilograms were determined to be healthy by physical examination (Texas A&M 
Veterinary Medical Park, College Station, TX, USA).  All goats were housed in groups 
of three within approved laboratory animal facilities for the duration of the study, and 
used under a protocol approved by the Texas A&M Institutional Animal Care and Use 
Committee. Animals were assigned to one of two groups (25 mm IO device in the wing 
of the ilium or 45 mm IO device in the proximal humerus).  Catheters utilized in this 
study were labeled for use in human patients 40 kilograms or greater in weight, and 
goats were randomly assigned to catheter locations.  
An intramuscular injection of 0.22 mg/kg xylazine (Butler Animal Supply, 
Dublin, OH) was administered, followed by intramuscular 11 mg/kg ketamine (Fort 
Dodge, Fort Dodge, IA) for induction of general anesthesia.  Areas surrounding 
cannulation sites were clipped and prepared aseptically, and sterile technique was used 
for all device placements. Intraosseous devices were inserted according to manufacturer 
instructions, following aseptic preparation of the skin and a subcutaneous injection of 
0.2 ml of lidocaine (Sparhawk Laboratories, Lenexa, KS) immediately over the insertion 
point.  The cannulas were then placed through the skin and bone using the EZ-IO® high-
powered drill.  Devices within the wing of the ilium were applied in the palpable dorsal 
crest, placing the needle parallel to the long axis of the bone (Figure 5) and radiographs 
were obtained to ensure proper placement.  Devices in the humerus were placed 
longitudinally within the head of the humerus as in the first study.   
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Figure 5.  Radiographic view (ventrodorsal) of intraosseous catheter placed in 
the right ilium. 
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In both, intramedullary placement was confirmed by firm seating and aspiration of blood 
and marrow contents.  An EZ Connect® cap was then attached after removal of the 
stylet.  Since study personnel were proficient at application within the humerus 
following the initial study, additional radiographs were not utilized to check placement 
in the second group.  Approximately 4 ml of blood was collected from the jugular veins 
of all animals for baseline aerobic and anaerobic cultures and CBC.  Culture samples 
were submitted to the TVMDL in 20 ml pediatric soy tryptinase blood culture media.  
Blood samples for CBC were also submitted to TVMDL. 
All other daily clinical monitoring, flushing, and criteria for removal were 
identical to the study one.  Since no evidence of bony change was observed in the initial 
study, post-removal radiographs were obtained only in those animals showing evidence 
of lameness, swelling, or elevated temperature for more than 24 hours after removal of 
devices.  Serum ELISA for Caprine Arthritis Encephalitis testing was also submitted to 
the TVMDL for two animals who showed persistent or intermittent lameness for greater 
than two weeks. 
 
2.3.  Statistical Analysis (Study Two)   
Time to removal of intraosseous catheters placed in the wing of the ilium and the 
proximal humerus were analyzed using Kaplan-Meier time to failure curves and 
compared using the log-rank test.  A p-value <0.05 was considered statistically 
significant.  All analyses were carried out using Intercooled Stata version 11.0 software 
(Stata Corp., College Station, TX, USA).  
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3.  STUDY ONE RESULTS 
 
3.1. Proximal Tibia  
Catheters in the tibia (n=3) were well tolerated, though some minor gait 
abnormalities were initially noted due to the placement of bandage material. Respective 
times of catheter removal for this group were at 18, 41, and 96 hours (Table 1).  The 
catheter removed at 18 hours was found to be completely displaced during the first 
exam.  No cultures were performed on this catheter, due to the high likelihood of 
environmental contamination beneath the bandage preventing accurate sample 
assessment.  The second catheter was also found displaced under the bandage material 
approximately 41 hours after insertion, and again was not submitted for culture for the 
same reason.  The final tibial catheter was removed after approximately 96 hours due to 
development of moderate lameness, though it was still patent and adequately seated at 
the time of removal.  This is also the same animal, goat number 0100, who showed a 
mild degree of increased opacity within the stifle joint on post-removal radiographs 
(Appendix A).  The goat was administered a long-acting intramuscular, broad-spectrum 
antibiotic at the time of removal, and had no further complications.  The animal also 
displayed no further sign of gait abnormalities after anesthetic recovery.  Due to the 
immediate resolution after removal of the device, the lameness was likely attributable to 
IO device bending and minor physical displacement.  No further complications were 
noted in the animal in the following weeks.  
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Table 1.  Study one survival times and removal criteria for intraosseous catheters in the 
jugular vein, proximal tibia, and proximal humerus 
______________________________________________________________________ 
 
 
 
_______________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
Animal 
Catheter Type/Site 
Time Removed 
(Hours) Removal Criteria 
163 Jugular  43 Non-patent 
166 Jugular  96 End Study 
161 Jugular 96 End Study 
6600 IO Cath Tibia (25 mm) 18 Displaced 
248 IO Cath Tibia (25 mm) 41 Non-patent 
0100 IO Cath Tibia (25 mm) 96 Lameness/swelling 
0250 IO Cath Humerus (25 mm) 67 Displaced 
0096 IO Cath Humerus (25 mm) 83 Displaced 
0069 IO Cath Humerus (25 mm) 88 Displaced 
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3.2. Proximal Humerus (25 mm Catheter)   
Catheters in the humerus (n=3) were also well tolerated, though it was noted that 
external portions of devices within the humerus began to deviate from the original angle 
of placement within the first 24 hours.  No immediate cause of the bending was noted 
during the exam periods, however, it may be assumed that the catheters were subjected 
to some degree of trauma due to the healthy, ambulatory nature of the animals in our 
study.  Though all external portions of the device became progressively deviated from 
their original angle -- some up to 90°-- all catheters remained well seated in the bone and 
patent for at least 3 days. Catheters placed within the humerus (n=3) were removed due 
to resistance to flushing at approximately 67, 83, and 88 hours, respectively (Table 1).  
Animal number 0069, whose catheter was removed at 88 hours, developed mild swelling 
and purulent discharge at the catheter placement site in the 24 hours prior to removal, 
and was administered one intramuscular dose of a long-acting broad-spectrum antibiotic.  
No complications were noted on observation after removal, and the goat was released to 
regular pasture housingwithout further incident.  No lameness resulting from device 
placement was observed in any animals within this group, and all animals remained 
bright, alert, and active throughout the study.   
 
3.3.  Jugular Catheters  
One jugular catheter was removed from one of three goats in this experimental 
group after 43 hours due to the inability to flush effectively subsequent to kinking within 
the vessel.  All other jugular catheters (n=2) remained patent until their removal, 
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coinciding with removal of the last remaining intraosseous devices at day four of the 
study (Table 1).  All animals were returned to their normal pasture housing, and no 
sequelae to the catheter or device placement at any site were noted on visual exam in the 
weeks following removal. 
 
3.4. Radiographs (Study One)   
Radiographs were taken of all animals assigned to both initial intraosseous 
groups immediately after placement.  They were taken again immediately after manual 
removal or unintentional displacement of the devices. All radiographs taken immediately 
after introduction of intraosseous catheters confirmed adequate placement, and did not 
show any evidence of damage to surrounding bone. Those taken following removal or 
dislocation of the devices also revealed healthy bone in most animals, with no evidence 
of fractures or other damage acquired during use of the devices (Appendix A).  One 
animal with a tibial catheter, goat number 0100, showed mildly increased opacity within 
the stifle joint.  This was the same animal whose catheter was removed due to lameness, 
but recovered fully (Table 1).   
 
3.5. Culture (Study One)  
Baseline blood cultures in the first study for animal numbers 166, 161, and 6600, 
were found to be negative for aerobic, anaerobic, and obligate anaerobic growth 
(Appendix B).  Three baseline cultures for goat numbers 0100, 0096, and 0069 showed 
growth of an aerobic Bacillus species. The remaining three cultures in goat numbers 163, 
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0248, and 0250 showed combinations of Bacillus sp., Micrococcus, Corynebacterium, 
alpha-hemolytic Streptococcus sp., and coagulase negative Staphylococcus sp. Blood 
culture at day three showed one negative culture (goat 0250).  Animal numbers 161, 
0100, 0096, and 0069 again showed growth of a Bacillus species, animal 166 showed 
growth of coagulase negative Staphylococcus species, and goat 163 was found to have 
one colony of branching, gram positive rod of an unknown significance.  Supplemental 
gene sequencing on this organism identified it as either belonging within the genera 
Brachyacterium or as a novel Dermabacteracea species.  Catheters submitted for 
cultures after removal on animals 0100 and 0069 showed growth of Bacillus sp.  One 
catheter from goat 0100 also showed a small amount of mixed bacterial growth, likely 
due to environmental contaminants.  Cultures from goat 0250 grew one colony of a gram 
positive, branching rod.  Supplemental gene sequencing identified the colony to be 
Micromonospora chalcea.  No anaerobic or obligate anaerobic growth was noted among 
samples at any time point.   
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4. SECOND STUDY RESULTS 
 
4.1. Wing of the Ilium   
Catheters (25 mm) placed in the crest of the ilium (n=9) were well tolerated by 
all animals.  However, eight of the devices became displaced within the first 24 hours 
(Table 2).  One catheter remained in place for approximately 43 hours, until it also 
became displaced and required removal (goat 250).  No animals in this group showed 
any lameness, swelling, or other clinical signs associated with the devices. No significant 
abnormal values were noted on CBC analyses in any goats in this experimental group 
(Appendix C) 
 
4.2. Proximal Humerus (45 mm Catheter)   
Similar to the study one, catheters were placed in the proximal humerus in a total 
of n=9 animals, but using a longer 45 mm catheter length.  The catheters in the humerus 
were well tolerated, but began to deviate from the original angle of placement within the 
first 24 hours. The majority of the catheters remained patent for several days, with 
respective removal times of approximately 22, 31, 46, 46, 48, 94, 95, 100, and 100 hours 
(Table 2).   
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Table 2.  Study two survival times for 45 mm intraosseous catheters in the proximal 
humerus and 25 mm IO catheters in the wing of the ilium 
_______________________________________________________________________ 
 
 
 
_______________________________________________________________________ 
 
 
 
 
 
 
 
 
Animal Catheter Type/Site Time Removed (Hours) Removal Criteria 
87 IO Cath Humerus (45 mm) 22 Non-patent 
07 IO Cath Humerus (45 mm) 31 Lameness/swelling 
29 IO Cath Humerus (45 mm) 46 Non-patent 
124 IO Cath Humerus (45 mm) 46 Non-patent 
132 IO Cath Humerus (45 mm) 48 Non-patent 
34 IO Cath Humerus (45 mm) 94 Non-patent 
137 IO Cath Humerus (45 mm) 95 Lameness/swelling 
131 IO Cath Humerus (45 mm) 100 Lameness/swelling 
88 IO Cath Humerus (45 mm) 100 Lameness/swelling 
0100 IO Cath Ilium (25 mm) 16 Fell out 
299 IO Cath Ilium (25 mm) 16 Fell out 
0099 IO Cath Ilium (25 mm) 16 Non-patent 
298 IO Cath Ilium (25 mm) 19 Fell out 
0069 IO Cath Ilium (25 mm) 19 Fell out 
248 IO Cath Ilium (25 mm) 22 Fell out 
0096 IO Cath Ilium (25 mm) 27 Fell out 
175 IO Cath Ilium (25 mm) 30 Fell out 
250 IO Cath Ilium (25 mm) 43 Fell out 
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4.3. Clinical Observations and Adverse Findings for Catheters in the Humerus 
Subjectively, the 45 mm catheters appeared to be slightly more resistant to 
bending than the 25 mm needles, however, additionally appeared to cause more soft-
tissue swelling around the insertion site following removal.  Also, in this portion of the 
study, four of the 45 mm catheters were removed due to mild to moderate lameness in 
animal numbers 137, 131, 34, and 88. These four animals were administered appropriate 
antibiotics and analgesics. Follow-up radiographs were obtained on the four animals 
showing signs of discomfort or lameness for greater than 72 hours (goat numbers 29, 
137, 131, and 134).  Images indicated that swelling was confined to the soft tissue 
surrounding the insertion site, and no significant bony changes were noted in two of 
these four animals. Goat number 137 was noted to have a small bony defect at the site of 
insertion on radiographs (Appendix A), and remained intermittently lame for nearly 
three weeks.  CBC showed normal white blood cell counts (Appendix D), and serum 
ELISA testing for Caprine Arthritis Encephalitis was negative.  Subsequent follow up 
radiographs after approximately two weeks showed good healing of the area and 
resolution of soft tissue swelling, and the goat recovered fully.   
A fourth animal, however, showed minimal improvement with clinical therapy 
(goat 29).  This goat’s catheter was removed on day two due to non-patency.  
Approximately two days later the goat developed a fever, swelling in the shoulder area, 
and became lame.  Antibiotics were administered and the fever resolved completely, but 
approximately one week after catheter removal, an abscess developed dorsal to the 
original catheter insertion site.  The abscess was drained and flushed, and culture showed 
 19
growth of Arcanobacterium pyogenes and Staphylococcus aureus.  The animal was 
subsequently treated with five days of Procaine Penicillin G at 25,000 units/kg 
(Agripharm Products, Westlake, TX).  Follow-up radiographs showed periosteal new 
bone and sclerosis around the glenoid/supraglenoid tubercles and greater tubercle of the 
humerus, as well as a lucency within the cranial glenoid/coracoid process (Appendix E).  
These findings were suggestive of possible infectious periostitis and osteomyelitis.   
CBC at that time showed a normal white blood cell count, and temperature remained  
normal.  Serum ELISA testing for Caprine Arthritis Encephalitis was negative.  An 
additional five days of antibiotic therapy was administered, as well as low dose 
dexamethazone 0.1 mg/kg.   
 
4.4. Statistical Results   
Time to removal of intraosseous catheters placed in the wing of the ilium and the 
proximal humerus were visualized using Kaplan-Meier time to failure curves and 
compared using the log-rank test (Figure 6). Time to failure was significantly longer for 
intraosseous catheters placed in the proximal humerus versus the wing of the ilium 
(p=0.0008). 
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Kaplan-Meier time to failure analysis for 25 mm IO catheters in the ilium  
and 45 mm IO catheters in the proximal humerus 
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Figure 6. Kaplan Meier failure functions for 45 mm interosseous catheters placed in the 
humerus (n=9) and 25 mm intraosseous catheters placed in the wing of the ilium (n=9). 
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4.5.  Radiographs (Study Two)  
Four animals receiving 45mm catheters in the humerus had evidence of some 
soft tissue swelling surrounding the insertion site in follow-up radiographs (goat 
numbers 29, 131, 137, and 34)(Appendix A). This was not an unexpected finding, and 
was visible or palpable during examination. One other animal in within this group, goat 
number 137, showed a small defect at the insertion site that healed well radiographically 
in the following weeks.   Goat number 29 demonstrated persistent lameness, despite 
antibiotic and analgesic therapy, and follow-up radiographs indicated development of 
early stage periostitis and osteomyelitis.  
 
4.6. Culture (Study Two)   
In the second study, all baseline cultures were negative (Appendix F).  No catheters 
in the ilium remained past 24 hours, and so no further blood cultures were submitted for 
these animals.  Also, no catheters were submitted from the ilium due to self 
displacement and the high likelihood of excessive environmental contamination. 
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 In the nine goats with catheters in the humerus, four blood cultures were 
submitted on day two of the study, and three of these (animal numbers 131, 34, and 88) 
showed growth of Bacillus species.  In the two samples that were submitted on day four, 
goat 131 showed growth of a gram positive rod, and goat 88 had no growth.  However, 
animals having positive blood and/or catheter cultures were not necessarily those who 
appeared lame at any point in the study, and vice versa, so it is likely that growth may 
have been due to environmental contamination during collection.  Catheters from the 
humerus submitted over the course of the experiment showed growth of Bacillus cereus, 
α-hemolytic Streptococcus, Staphylococcus aureus, and Enterococcus sp.  For the goat 
who developed an abscess and radiographic evidence of osteomyelitis after removal 
(goat 29), neither of the bacteria cultured from the abscess were present in blood or 
catheter culture.  Growth noted on blood cultures was likely attributable to 
environmental and/or skin contaminants acquired during the blood collection procedure 
or removal of IO devices.  
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5. DISCUSSION 
 
 
In general, the intraosseous devices were well tolerated by the animals within 
study one, and those in the humerus and tibia were functionally similar to jugular 
catheters.  Most remained functional for several days with few complications or notable 
long term health effects, with the exception of one goat.  The majority of animals from 
the IO study groups exhibited no radiographic evidence of damage or structural change 
within the surrounding bone, again with the exception of one animal that showed a 
mildly increased opacity within the stifle joint.  All other devices remaining in after the 
first day during study one were removed solely due to external deviation significant 
enough to affect overall patency.   
In the study two, devices were also well-tolerated within the humerus and the 
wing of the ilium, though there was a significant difference (p=0.0008) in the time to 
failure of the catheters between the two groups when p<0.05.  Catheters within the ilium 
became displaced much more quickly than all other locations, potentially making it a 
less useful location in clinical practice.  Due to the mechanical trauma and bending that 
was noted with the sites in study one, it was our hope that catheters in the ilium might be 
subjected to less mechanical force during normal movements, and thus remain patent 
and in place for a longer time.  Conversely, these were significantly less resilient in our 
study. This may possibly be due to a thinner cortex to seat the catheter in.  Although a 45 
mm needle could potentially be used in this site, initial placement would be more 
difficult due to the narrow space and angle of the marrow cavity, making it much more 
likely that the catheter would pass through the opposite cortex and not function properly.  
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Based on our results, the wing of the ilium would not be a recommended placement site 
in an ambulatory animal compared to a site in the humerus or tibia.  It may still 
potentially be used in a recumbent patient if needed, but still may not be as resistant to 
displacement during movement or rotation of the animal. 
We also observed a higher incidence of associated lameness and swelling in 
animals that received a 45 mm catheter in the humerus during the second study, and in 
one case, osteomyelitis.  Radiographs showed that there was no significant bony change 
or evidence of fracture in nearly all of the goats, and swelling was predominantly soft-
tissue and confined to the area immediately over the site of insertion.  Also, aside from 
one animal, the majority of goats with swelling and lameness were those whose catheters 
remained in until an approximately four day timepoint.  Eight of nine goats ultimately 
did well clinically, and no long term complications were observed in the following 
weeks after resolution. One animal developed an abscess and subsequent periostitis and 
osteomyelitis, which is a rare side effect also reported during use in human medicine.  
The exact reason for the increase in swelling and clinical signs in this group is not 
known, however, the longer needle size could potentially cause more soft tissue 
disturbance on insertion at the angle used. Also, since most swelling was noted 
following removal of the catheters, it may be partly attributable to the fact that removal 
of the 45mm needles required significantly more effort due to deeper seating in the bone, 
which could likely have resulted in more soft tissue disturbance at that time.  Our 
experiment showed that this size catheter in the humerus is useful, but that side-effects in 
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this group were notable and should be taken into consideration when used in a practice 
setting.   
In our study, the devices placed in the humerus appeared to remain functional 
and in place longer than those in the tibia or wing of the ilium, and all were comparable 
to the jugular catheter group in terms of initial usefulness for injectables in an 
ambulatory animal.  In human medicine, however, automatic intraosseous devices are 
commonly used within the human tibia, and have also been utilized in some previous 
studies on animal models under surgical anesthesia with good results12,14,15,21,29,42,53,54,55.  
Studies in animal models have also demonstrated that adequate flow rates may be 
obtained using the tibia and malleolus, but that higher rates are attainable when using a 
location within the humerus and femur54.  Animals in our study were healthy and active, 
so external portions of the IO catheters were likely subjected to significantly more 
movement and trauma than in the type of clinical situation where they would most likely 
be utilized.  In our study, the thicker cortex of the humerus in the goats may have 
provided greater physical stability than the thinner cortex of the tibia.  Also, the exiting 
angle of the cap in the humerus was such that it likely could withstand torque and forces 
better than the tibial device caps, which exit the skin at a 90° angle medially.  However, 
all devices remaining in place were clinically comparable in terms of initial function, 
and could be easily utilized for administration of fluids and medications in an emergency 
clinical situation. One could consider the healthy status of the goats within this study a 
limitation.  However, most of the IO devices place within the long bones remained 
functional and in place remarkably well.   
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The IO method would likely be used as an alternative emergency bridging 
method in compromised, hypovolemic, and possibly recumbent animals.  In such cases, 
these devices would be exceptionally useful and provide a means of quick fluid, blood, 
or drug administration until venous access could be acquired at a later time.  Proximal 
humerus devices in our study lasted three to four days, and one tibial device lasted four 
days prior to removal. In a recumbent or ill animal, these would likely remain patent for 
an even longer period of time, as they would not be subjected to the amount of activity 
and trauma placed on them by healthy animals.  Though our study indicated that 
catheters may generally remain in safely for greater than the currently approved 24 hour 
time point, caution should be extended, as more side-effects were noted as time 
increased. 
All animals remained bright, alert, and active throughout the study.  Some 
animals did show growth on baseline and post-placement blood cultures, and on catheter 
cultures.  However, the bacteria species that were isolated are ubiquitous within soil and 
within farm animal species.  A total of two goats within the first study group were 
treated with antibiotics after removal of the device as a precaution for swelling or 
associated lameness, but all of the other seven animals remained healthy and active with 
no observed clinical sequelae whether or not positive cultures were obtained.  Within the 
second study group (n=18), a total of four animals were treated with antibiotics after 
developing mild lameness and/or swelling.  Those goats exhibiting clinical signs also did 
not show a particular correlation with changes noted on the CBC or culture growth 
results.  While it is advisable to closely monitor any ill or immunocompromised patients 
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with either a jugular and/or intraosseous catheter in place, it is most likely that our 
positive cultures were due to skin and environmental contaminants during blood 
collection and device removal, though additional studies would be required to confirm 
this interpretation of the data. 
The number of animals used for our studies was small, as this was an initial 
comparison of efficacy and assessment of tolerance and duration of use.  However, we 
determined that with proper placement and management, these intraosseous devices may 
be left in place for greater than 24 hours (which the device is currently approved for 
during use in human medicine) with few complications.  Future studies may explore use 
in a larger number of animals and/or clinically ill animals.  One may also consider 
different anatomical locations that may potentially provide similar stability, but perhaps 
would be subject to less force by the animal’s body weight during normal activity, or in 
a recumbent animal.   
The EZ-IO® handheld drill is easy to use, and can be utilized properly after brief 
instruction.  They  are portable and generally take under 1 minute to prepare and insert 
with a 96%-100% successful placement rate6,31.  Previous studies in human medicine 
have shown that the majority of nurses, medical students, physicians, and first 
responders are all able to successfully place these IO devices quickly within a clinical 
setting after a short training session describing its use11.  This training approach could 
easily be extended to technicians and veterinarians within small and large animal clinical 
practice, and also in teaching institutions.   
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 These devices also have a variety of potential applications for ambulatory large 
animal practice.  The catheter may be placed with local anesthesia, reducing the need for 
risky general anesthesia in a compromised animal.  Large volumes of fluid may be 
quickly administered with the aid of a pressurized system, and in most cases blood can 
be collected if needed, especially in young animals. Previous studies have shown that lab 
readings and cultures performed on blood collected from the bone marrow are clinically 
comparable to that of peripheral blood1,7,9,20,22,34,55.  Care should be taken to avoid 
immature growth plates in pediatric patients, but some studies have noted that significant 
growth defects did not result from penetration of the plates in swine10.   
Agents administered into the intraosseous space are first absorbed into venous 
sinusoids, then travel rapidly into the central venous channel and systemic 
circulation12,41,48,49, reaching the heart within 10 seconds.  Studies have also shown that 
many drugs, such as glucose, lidocaine, calcium chloride, and epinephrine reach a peak 
effect within 30-45 seconds33,44.  An added benefit of this system in emergency cases is 
that these sinuses remain open during shock or hypovolemic situations, unlike many 
peripheral veins23,32,50.  Additional studies have shown that in most cases, medications 
and anesthetic administered at an intravenous dose via an intraosseous route have equal 
distribution and effect4,9,21,26,28,29,33,37,42,44,45,52,53,55.  Some antibiotics, such as ceftriexone, 
may reach slightly lower serum levels when given IO37, though are generally 
comparable. This may need to be taken into consideration if a loading dose of antibiotic 
is desired, as in cases of suspected sepsis or meningitis.   In such situations, the highest 
recommended manufacturer dose may be warranted when being administered 
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intraosseously.   In addition, intraosseous fluids and blood transfusions are equally as 
effective as those given intravenously36,43.     
Some contraindications to use are infection, injury, and cellulitis over the 
insertion point, or if there is damage or fracture of the bone intended for use13,55.  The 
use of intraosseous devices is also not recommended in patients known to be bacteremic.  
While most fluids and medications may be given IO, there are some known to cause 
damage to bone marrow. Very alkaline or hypertonic solutions should be diluted prior to 
administration to help avoid medullary damage and subsequent development of 
osteomyelitis.  Additionally, several human cases of osteomyelitis have been 
documented after hypertonic solutions were administered IO in children, including 5% 
sodium chloride (NaCl), which may cause marrow necrosis and some damage to the 
endosteum3,30. Sodium bicarbonate injections have also been noted to cause mild 
inflammatory changes within the surrounding bone marrow cells45,47 and minor increases 
in skeletal turnover24.  Additionally, Dextran 70 can cause minor disruption of the 
medullary cavity.   
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Many of these clinical cases of osteomyelitis were observed in the late 1940’s. The 
current percentage of resulting osteomyelitis in human patients is less than 0.6% of all 
cases41, likely due to improvements in aseptic technique and antibiotic administration. 
There is also some concern about potential for fat and bone marrow pulmonary emboli 
after aggressive intraosseous infusion17,32.  However, emboli may be found in 
traumatized patients with or without damage to bone, and most cases, these risks are 
often outweighed by the many benefits of IO cannulation in emergency situations.  
Complication rates are relatively low, though the devices should be monitored closely.  
Punctures in the opposite cortex and extravasation of fluids may 
result in decreased efficacy, pain, and compartmental syndrome after placement or with 
multiple attempts at cannulation8,27,40.  Unintentional displacement is considered one of 
the most common complications associated with intraosseous catheters. 
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6. CONCLUSIONS 
 
In summary, the IO devices are simple to use, portable, quickly placed, require 
minimal training to use, and have immense potential for use within many different 
veterinary settings when intravenous access is not immediately accessible.  The 
automatic drill devices are useful in larger or adult bones where manual catheter 
placement may be difficult and time consuming.  Several studies have shown no long 
term, negative sequelae in swine10,24,51,53, and our initial study on a goat model further 
supports these previous findings.  The EZ-IO® device in particular may be used with or 
without local anesthesia, saving valuable time and resources. Although venous access 
remains the gold standard for emergency drug and fluid administration, intraosseous 
devices provide a valuable alternative bridging technique for quick administration of 
potentially life-saving fluids and therapeutics in clinical and field settings. 
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APPENDIX A 
 
RADIOGRAPHIC INTERPRETATIONS (STUDY ONE): 
 
Radiographs reviewed by Bunita Eichelberger DVM, MS, Dipl. ACVR 
 
Note: The interpretation is of the radiographic studies provided.  As 50% bone loss is 
required to be detected radiographically, subtle bone lesions (i.e. infection), may be 
occurring but is not radiographically detectable.  
 
November 16, 2009 
 
Goat Y-0069  
Radiographic Findings: Left humerus.  Open physes are expected for the age of the 
animal.  A 5.2 cm catheter is inserted medial to the greater tubercle in a proximal to 
distal direction within the medullary cavity of the proximal humeral diaphysis; the 
catheter extends approximately 2.8 cm into the medullary cavity.   
Radiographic Impressions: Adequate catheter placement.  There is no evidence of 
implant failure, fractures or infection.  
 
Goat Y-0096 
Radiographic Findings: Left humerus.  Open physes are expected for the age of the 
animal.  A 6.2 cm catheter is inserted medial to the greater tubercle in a proximal lateral 
to distal medial direction within the medullary cavity of the proximal humeral diaphysis; 
the catheter extends approximately 3.0 cm into the medullary cavity.   
Radiographic Impressions: Adequate catheter placement.  There is no evidence of 
implant failure, fractures or infection.  
 
Goat Y-6600 
Radiographic Findings: Left tibia.  Open physes are expected for the age of the animal.  
A 3.5 cm catheter is inserted in a cranial to caudal direction within the medullary cavity 
of the proximal tibia diaphysis.  Bandage material surrounds the tibia.  
Radiographic Impressions: Adequate catheter placement.  There is no evidence of 
implant failure, fractures or infection.  
 
Goat O-250 
Radiographic Findings: Open physes are expected for the age of the animal. 
   
Right Humerus.  A 3.4 cm catheter is inserted in a cranial to caudal direction within the 
medullary cavity of the proximal humeral diaphysis.  Bandage material surrounds the 
humerus.  
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Left Humerus.  A 5.2 cm catheter is inserted medial to the greater tubercle in a proximal 
to distal direction within the medullary cavity of the proximal humeral diaphysis; the 
catheter extends approximately 3.2 cm into the medullary cavity.  
 
Radiographic Impressions: Adequate catheter placement within the proximal humerus, 
bilaterally.  There is no evidence of implant failure, fractures or infection.  
 
Goat O-248 
Radiographic Findings: Left tibia.  Open physes are expected for the age of the animal.  
A 3.2 cm catheter is inserted in a cranial to caudal direction within the medullary cavity 
of the proximal tibia diaphysis.  Tubing is identified external to the catheter.  
Radiographic Impressions: Adequate catheter placement.  There is no evidence of 
implant failure, fractures or infection.  
 
Goat O-100 
Radiographic Findings: Left tibia.  Open physes are expected for the age of the animal.  
A 3.5 cm catheter is inserted in a cranial to caudal direction within the medullary cavity 
of the proximal tibia diaphysis.  A T-port and tubing is identified external to the catheter.  
Radiographic Impressions: Adequate catheter placement.  There is no evidence of 
implant failure, fractures or infection.  
 
November 17, 2009 
 
Goat O-250 
Radiographic Findings: The study is compared to the one made on November 16, 2009.  
Right humerus.  The catheter is not visualized.  A cylindrical lucency is identified within 
the medullary bone of the proximal humerus where the catheter was previously placed.  
There is no evidence of infection or fractures.  
Left humerus.  The portion of the catheter external to the proximal humerus is sharply 
angulated; the catheter remains similarly positioned without evidence of catheter 
retraction.  There is no evidence of infection or fracture.  
 
Goat Y-6600. 
Radiographic Findings: Left tibia.  The study is compared to the one made on November 
16, 2009.  The catheter is not visualized.  There is no evidence of infection or fractures.  
 
 
November 18, 2009 
 
Goat O-248 
Radiographic Findings and Impressions: Left tibia.  The study is compared to the one 
made on November 16, 2009. The catheter is not visualized.  A cylindrical lucency is 
identified within the medullary bone of the proximal tibia where the catheter was 
previously placed.  There is no evidence of osteomyelitis or fractures.  Soft tissue 
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swelling and gas opacities are identified within the soft tissues along the medial aspect 
of the proximal tibia; this may be secondary to catheter placement although edema, 
cellulitis or abscess cannot be excluded.  
 
November 19, 2009 
 
Goat O-250  
Radiographic Findings and Impressions:   Left humerus.  The study is compared to the 
November 16 and 17, 2009.  The catheter is retracted; approximately 1.5 cm remains 
within the humeral diaphysis.  Subsequent images demonstrate complete removal of the 
catheter.   A small elliptical mineral opacity is identified along the cranial margin of the 
humerus which may represent a small avulsed fragment that occurred during catheter 
placement.  There is focal soft tissue swelling along the cranial margin of the humerus 
which may be associated with the previous catheter although edema, cellulitis or abscess 
cannot be excluded.  There is no evidence of osteomyelitis.  
 
November 20, 2009 
 
Goat Y-0069 
Radiographic Findings and Impressions: Left humerus.  The study is compared to the 
one made on November 16, 2009.  The catheter is retracted; approximately 1.6 cm 
remains within the proximal humerus.  The external portion of the catheter is angulated 
and a T-port is identified attached to the catheter.  Subsequent radiographic projections 
demonstrate complete removal of the catheter.  There is focal soft tissue swelling along 
the cranial margin of the humerus which may be associated with the previous catheter 
although edema, cellulitis or abscess cannot be excluded.  There is no evidence of 
osteomyelitis or fractures.  
 
Goat Y-0096 
Radiographic Findings and Impressions: Left humerus.  The study is compared to the 
one made on November 16, 2009.  The catheter has been removed.  The cranial margin 
of the greater tubercle is irregular which is similar to the previous examination.  There is 
no evidence of osteomyelitis or fractures.  
 
Goat Y-0100 
Radiographic Findings and Impressions:  Left tibia.  The study is compared to the one 
made on November 16, 2009.  The catheter has been removed; cylindrical lucencies are 
identified within the proximal tibia diaphysis in the region of the previous catheter.  In 
one of the projections, a catheter is identified within the soft tissues of the cranial tibia.  
There is soft tissue swelling and subcutaneous gas within the tissues surrounding the 
proximal tibia, especially along the cranial and medial aspects of the tibia.  There is 
increased opacity within the stifle joint.  
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The soft tissue swelling may be associated with the previous catheter although edema, 
cellulitis or abscess cannot be excluded.  Possible left stifle effusion; early septic arthritis 
cannot be excluded.  There is no evidence of fractures. 
 
RADIOGRAPHIC INTERPRETATIONS (STUDY TWO): 
 
April 26, 2010 
 
Goat:  248 
Radiographic findings: Six views of the pelvis are available for review.  The first four 
radiographs were made to evaluate for radiographic technique and positioning.  Image 
#5 and image #6 were made after intraosseous catheter placement.  An intra-osseous 
catheter has been inserted within the dorsal medial margin of the right ilial wing; focal 
gas opacities are identified surrounding the margin/tip of the catheter.  A T. port has 
been placed on the external surface of the catheter. 
Radiographic impressions: Adequate intraosseous catheter placement without apparent 
complications.  The gas opacities surrounding the intraosseous catheter are most likely 
iatrogenic. 
 
Goat:  175 
Radiographic findings: Two views of the pelvis are available for review.  An 
intraosseous catheter has been positioned along the cranial lateral margin of the right 
ilial wing with termination within the medullary cavity AP port extends from the 
external portion of the catheter.  Osseous structures of the pelvis including sacroiliac 
joints, right and left coxofemoral joints are radiographically normal. 
Radiographic impressions: Adequate intraosseous catheter placement without apparent 
complications. 
 
Goat: 298 
Radiographic findings: Three views of the pelvis are available for review.  An 
intraosseous catheter has been positioned along the cranial lateral margin of the right 
ilial wing with termination into the medullary cavity.  A T. port is positioned onto the 
external portion of the catheter.  Osseous structures of the pelvis including sacroiliac 
joints, right and left coxofemoral joints are radiographically normal. 
Radiographic impressions: Adequate intraosseous catheter placement without apparent 
complications. 
 
Goat:  0069 
Radiographic findings: Three views of the pelvis are available for review.  An 
intraosseous catheter has been inserted within the dorsal medial margin of the right ilial 
wing.  A T. port has been placed on the external surface of the catheter.  Osseous 
structures of the pelvis including sacroiliac joints, right and left coxofemoral joints are 
radiographically normal. 
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Radiographic impressions: Adequate intraosseous catheter placement without apparent 
complications. 
 
Goat: 250 
Radiographic findings: Three views of the pelvis are available for review.  An 
intraosseous catheter has been inserted along the cranial lateral margin of the right ilium 
with insertion into the medullary cavity.  A T. port has been placed on the external 
surface of the catheter.  Osseous structures of the pelvis including sacroiliac joints, right 
and left coxofemoral joints are radiographically normal. 
Radiographic impressions: Adequate intraosseous catheter placement without apparent 
complications. 
 
Goat:  0096 
Radiographic findings: Three views of the pelvis are available for review.  An 
intraosseous catheter has been inserted along the cranial lateral margin of the right ilial 
wing with termination within the medullary cavity.  A T. port has been placed on the 
external surface of the catheter.  Pelvic structures including sacroiliac joints, right and 
left coxofemoral joints are radiographically normal. 
Radiographic impressions: Adequate intraosseous catheter placement without apparent 
complications. 
 
Goat:  0100 
Radiographic findings: An intraosseous catheter has been positioned along the cranial 
medial margin of the right ilial wing with termination into the medullary cavity.  A T. 
port has been placed onto the external surface of the catheter.  Osseous structures of the 
pelvis including sacroiliac joints, right and left coxofemoral joints are radiographically 
normal. 
Radiographic impressions: Adequate intraosseous catheter placement without apparent 
complications. 
 
Goat:  0099 
Radiographic findings: Three views of the pelvis are available for review.  An 
intraosseous catheter has been inserted along the lateral aspect of the right ilial wing 
with termination within the medullary bone.  A T. port has been placed on the external 
surface of the catheter.  Osseous structures of the pelvis including sacroiliac joints, right 
and left coxofemoral joints are radiographically normal. 
Radiographic impressions: Adequate placement of intraosseous catheter. 
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Goat:  299 
Radiographic findings: Five views of the pelvis are available for review.  An 
intraosseous catheter has been inserted with positioning along the cranial and lateral 
margin of the right ilial wing.  On the ventral dorsal views, the catheter appears to be 
external to the medullary cavity of the right ilium.  Osseous structures of the pelvis 
including sacroiliac joints, right and left coxofemoral joints are radiographically normal.  
Open physes are expected for the age of the animal. 
Radiographic impressions: Suspect malpositioned catheter.  Recommend 
reinserting/repositioning catheter into the medullary bone of the right ilium. 
 
Goat: 131 
Radiographic findings: Five views of the right humerus are available for review.  
Radiographs were made after removal of a previously placed intraosseous catheter.  An 
intraosseous catheter is not identified within the radiographic projections.  An irregularly 
marginated bony defect is identified within the greater tubercle; small mineral opacities 
extend from the defect.  A well-circumscribed lucency extends into the medullary 
epiphysis of the greater tubercle; a circular region of sclerosis is identified in the center 
of this lucency.  The articular surface of the scapulohumeral joint is smooth and well 
aligned; soft tissue structures of the shoulder are radiographically normal. 
Radiographic impressions: The focal osseous defect within the greater tubercle is most 
likely related to previous catheter placement.  The focal lucency and sclerosis of the 
medullary bone may represent bone edema, osteomyelitis or infarction.  Repeat 
radiographs are recommended in 7-14 days for further diagnostic evaluation. 
 
Goat: 137  
Radiographic findings: Four views of the right humerus are available for review.  
Radiographs were made after removal of a previously placed intraosseous catheter.  An 
intraosseous catheter is not identified within the radiographic projections.  An irregularly 
marginated bony defect is identified within the greater tubercle; small mineral opacities 
extend from the defect.  The greater tubercle of the humerus is sclerotic.  A well-
circumscribed lucency extends into the medullary epiphysis of the greater tubercle; a 
circular region of sclerosis is identified in the center of this lucency.  The articular 
surface of the scapulohumeral joint is smooth and well aligned.  There is soft tissue 
swelling along the cranial and lateral margins of the scapulohumeral joint. 
Radiographic impressions: A focal osseous defect within the greater tubercle is most 
likely related to previous catheter placement however the extent and sclerosis is 
suspicious for an incomplete fracture.  The focal lucency and sclerosis of the medullary 
bone may represent bone edema, osteomyelitis or infarction.  Differentials for the soft 
tissue swelling include edema, hemorrhage, hematoma, abscess, or cellulitis.  Repeat 
radiographs are recommended in 7-14 days for further diagnostic evaluation. 
Goat: 29 
Radiographic findings: Four views of the right humerus are available for review.  
Radiographs were made after removal of a previously placed intraosseous catheter.  An 
intraosseous catheter is not identified within the radiographic projections.  An irregularly 
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marginated bony defect is identified within the greater tubercle; small mineral opacities 
extend from the defect.  There is soft tissue swelling along the cranial and lateral 
margins of the scapulohumeral joint. The articular surface of the scapulohumeral joint is 
smooth and well aligned; soft tissue structures of the shoulder are radiographically 
normal. 
Radiographic impressions: The appearance of the greater tubercle is most likely related 
to previous catheter placement with focal periosteal new bone suggestive of periostitis.  
Differentials for the soft tissue swelling include edema, hemorrhage, hematoma, abscess, 
or cellulitis.  Repeat radiographs are recommended in 7-14 days for further diagnostic 
evaluation. 
 
Goat: 34  
Radiographic findings: Five views of the right humerus are available for review. 
Radiographs were made after removal of a previously placed intraosseous catheter.  An 
intraosseous catheter is not identified within the radiographic projections.  An irregularly 
marginated bony defect is identified within the greater tubercle.  There is soft tissue 
swelling along the cranial and lateral margins of the scapulohumeral joint. The articular 
surface of the scapulohumeral joint is smooth and well aligned; soft tissue structures of 
the shoulder are radiographically normal. 
Radiographic impressions: The appearance of the greater tubercle is most likely related 
to previous catheter placement.  Soft tissue swelling; differentials include edema, 
hemorrhage, hematoma, abscess or cellulitis.  Repeat radiographs are recommended in 
7-14 days for further diagnostic evaluation.  
 
June 15, 2010 
 
Goat: 137 
Radiographic findings: Four views of the right humerus are available for review.  The 
study is compared to the radiographs made on May 26, 2010.  The previously described 
focal osseous defect within the greater tubercle is filling in with osseous callus; the 
greater trochanter margins are mildly sclerotic.  The well-circumscribed lucency 
extending into the medullary epiphysis is static in appearance; there is preservation of  
the trabecular bone.  There is less soft tissue swelling than on the previous examination. 
Radiographic impressions: Resolving soft tissue swelling and healing defect within the 
greater tubercle.  As the focal lucency and sclerosis of the medullary bone has not 
progressed, bone edema or infarction is possible; osteomyelitis is considered unlikely.   
 
Goat: 29 
Radiographic findings: Three views of the right humerus are available for review.  The 
study is compared to the radiographs made on May 26, 2010.  The previously described 
soft tissue swelling has improved.  Periosteal new and sclerosis is identified surrounding 
the distal scapula including region of the glenoid and supraglenoid tubercle.  Periosteal 
new bone is identified along the margin of the greater tubercle.  The humeral head is 
sclerotic although scapulohumeral joint margins are smooth.  A lucency is identified 
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within the cranial glenoid/coracoid process.  The previously described defect within the 
greater tubercle is similar. 
Radiographic impressions: Although there is resolving soft tissue swelling, the bony 
changes are suggestive of an infectious periostitis and osteomyelitis; septic arthritis 
cannot be excluded.  Repeat radiographs are recommended in 5-7 days to follow 
progression of the osseous changes. 
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APPENDIX B 
 
 
CULTURE RESULTS FOR CATHETERS IN THE JUGULAR VEIN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Animal 
 
Blood culture results 
 
Day 0                                       Day 3 
Removal 
time (hrs) 
Removal 
Criteria 
163 -Bacillus sp. 
-Micrococcus sp. 
-Brachybacterium or novel     
Dermabacteracea sp. 
n/a 43 Non-patent 
166 No growth Coagulase neg. 
Staphylococcus 
96 End study 
161 No growth 
 
-Bacillus sp. 96 End study 
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CULTURE RESULTS FOR 25 MM CATHETERS IN THE PROXIMAL TIBIA 
                                                                                                                                                                    
 
 
 
 
 
    
 
 
 
 
 
 
 
 
Animal 
 
Blood culture results 
 
Day 0                          Day 3 
Catheter 
culture 
Removal 
time (hrs) 
Removal 
Criteria 
6600 no growth n/a n/a 
 
18 Displaced 
248 -Bacillus sp. 
-Corynebacterium 
-α-hemolytic   
Streptococcus 
n/a n/a 
 
41 Non-patent 
0100 -Bacillus sp. 
 
-Bacillus sp. -Bacillus sp. 
-mixed bact 
growth 
 
96 Lameness 
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CULTURE RESULTS FOR 25 MM CATHETERS IN THE PROXIMAL 
HUMERUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Animal 
 
Blood culture results 
 
Day 0                             Day 3 
Catheter 
culture 
Removal 
time (hrs) 
Removal 
Criteria 
0096 -Bacillus sp. Bacillus n/a 
 
67 Displaced 
0250 -Bacillus sp. 
-coagulase neg. 
Staphylococcus 
no growth Micromonospora 
chalcea 
 
83 Displaced 
0069 -Bacillus sp. Bacillus sp. Bacillus cereus 
 
88 Displaced 
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APPENDIX C 
 
 
DAY 0 CBC RESULTS: IO CATHETERS IN THE WING OF THE ILIUM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Normal Ranges: 
(WBC) Total WBC:  4000-13000/ul 
(ANC) Abs Neutrophils: 1200-7200/ul 
(ALC) Abs lymphocytes: 2000-9000/ul 
Animal   Day 0 
Results 
248 WBC 15000 
 ANC 9000
 ALC 6000
175 WBC 7500
 ANC 4650
 ALC 2775
298 WBC 11500
 ANC 6900
 ALC 4255
0069 WBC 11800
 ANC 7198
 ALC 4366
250 WBC 19100
 ANC 12797
 ALC 6303
0096 WBC 14300
 ANC 11297
 ALC 3003
0099 WBC 14000
 ANC 10640
 ALC 3220
0100 WBC 16000
 ANC 10240
 ALC 5760
299 WBC 8300
 ANC 4731
 ALC 3403
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APPENDIX D 
 
DAY 0, 2, AND 4 CBC RESULTS: 45 MM IO CATHETER IN HUMERUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal Ranges: 
(WBC) Total WBC:  4000-13000/ul 
(ANC) Abs Neutrophils: 1200-7200/ul 
(ALC) Abs lymphocytes: 2000-9000/ul 
 
 
 
Animal   Day 0 
Results 
Day 2 
Results 
Day 4 
Results 
Follow-up 
Results  
(day 25) 
29 WBC 13300 11600 
 ANC 6118 5104 
 ALC 7182 6264 
131 WBC 12100 14300 15000  
 ANC 7986 6149 5850  
 ALC 4114 7722 9000  
137 WBC 14600 17500   
 ANC 10512 9975  
 ALC 4088 7525  
34 WBC 17900 16800  
 ANC 13604 9912  
 ALC 3580 6216  
88 WBC 14300 20000 14500  
 ANC 10582  12400 9570  
 ALC 3432 6400 4495  
124 WBC 7340  
 ANC 1028  
 ALC 5138  
132 WBC 8870  
 ANC 6564  
 ALC 1951  
87 WBC 13100  
 ANC 4716  
 ALC 4454  
7 WBC 10500  
 ANC 6930  
 ALC 3360  
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APPENDIX E 
 
 
 
RADIOGRAPHIC VIEW OF POST REMOVAL PERIOSTITIS AND 
OSTEOMYELITIS 
 
 
                                            
 
 
Radiographs (goat number 29) showing periosteal new bone and sclerosis around the 
glenoid/supraglenoid tubercles and greater tubercle of the humerus, as well as  a lucency 
within the cranial glenoid/coracoid process.  Findings were suggestive of possible 
infectious periostitis and osteomyelitis.  
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APPENDIX F 
 
 
 
CULTURE RESULTS FOR 45 MM IO CATHETERS IN THE HUMERUS 
 
 
 
 
 
Animal 
 
Blood cultures 
 
   Day 0           Day 2           Day 4      
Catheter culture Removal 
after 
Removal 
Criteria 
29 No growth n/a n/a -Bacillus cereus 
-A-hemo Strep 
<48hrs 
(2d) 
Non-patent 
131 No growth Bacillus sp. 
 
Gm + rod Enterococcus sp. 96hrs (4d) Lameness 
137 No growth No growth n/a - Staph aureus 
-A-hemo Strep 
<96 hrs 
(4d) 
Lameness 
34 No growth Bacillus sp. n/a n/a <96hrs 
(4d) 
Non-patent, 
displacement 
88 No growth Bacillus sp. No growth -Gm- nonfermenter 
- A-hemolytic 
Strep 
96 hrs (4d) Lameness 
124 No growth n/a n/a - Bacillus sp. 
- Coag neg Staph 
<48hr (2d) Non-patent, 
displacement 
132 No growth n/a n/a Enterococcus sp. <48hr (2d) Non-patent 
87 No growth n/a n/a No growth <24hr (1d) Non-patent 
7 No growth n/a n/a n/a 24hr (1d) Lameness, 
swelling 
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